Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study
- Publication date
- 1 January 2018
- Publisher
- 'Springer Science and Business Media LLC'